This article demonstrates a murine model to study the development of myointimal hyperplasia (MH) after aortic balloon injury.
The use of animal models is essential for a better understanding of MH, one major cause for arterial stenosis.In this article, we demonstrate a murine balloon denudation model, which is comparable with established vessel injury models in large animals. The aorta denudation model with balloon catheters mimics the clinical setting and leads to comparable pathobiological and physiological changes. Briefly, after performing a horizontal incision in the aorta abdominalis, a balloon catheter will be inserted into the vessel, inflated, and introduced retrogradely. Inflation of the balloon will lead to intima injury and overdistension of the vessel. After removing the catheter, the aortic incision will be closed with single stiches. The model shown in this article is reproducible, easy to perform, and can be established quickly and reliably. It is especially suitable for evaluating expensive experimental therapeutic agents, which can be applied in an economical fashion. By using different knockout-mouse strains, the impact of different genes on MH development can be assessed.
Arterial stenosis in coronary and peripheral arteries has a large effect on the morbidity and mortality of patients1. One underlying pathological mechanism is myointima hyperplasia (MH), which is characterized by increased proliferation, migration, and synthesis of extracellular matrix proteins from vascular smooth muscle cells (SMC)2. SMC are located in the media layer of the vessel and migrate upon stimulation to the surface of the lumen. Stimulatory signals include growth factors, cytokines, cell-cell contact, lipids, extracellular matrix components, and mechanical shear and stretch forces3,4,5,6. Injuries of the vessel wall, pathological or iatrogenic, cause endothelial cell and smooth muscle cell damage and stimulate inflammatory reactions, and thus lead to MH7.
Different animal models are currently available to study arterial injury and myointima hyperplasia. Large animals like pigs or dogs have the advantage of sharing a similar artery and coronary anatomy with humans and are especially suitable for studies investigating angioplasty techniques, procedure, and devices8. However, pig models have the drawback of higher thrombogenicity9,10, while dogs only have a mild response to vessel injury11. In addition, all large animal models require special housing, equipment, and staff, which are connected with high costs and are not always available at an institution. Small animal models include rats and mice. Compared to rats, mice have the advantages of lower cost and the existence of a variety of knock out models. The model described in this video can be combined with ApoE-/- mice fed with a western diet to closely mimic the clinical setting of angioplasty in atherosclerotic vessels12. Previous models induced vascular injury via wire injury13, fluid desiccation14, spring15, or cuff injury16. Since the nature of the injury will greatly impact the development and constitution of MH, using a balloon catheter to induce vessel injury is the best way to mimic the clinical setting.
In this article we describe a novel method to induce MH with a balloon catheter in mice. The use of a balloon catheter (1.2 mm x 6 mm) with a RX-Port (Figure 1A) allows the scraping of the intimal layer and, at the same time, the induction of an overdistension of the vessel. Both of these factors are important triggers for the development of MH. The observation time for this model is 28 days17.
Animals received humane care in compliance with the Guide for the Principles of Laboratory Animals, prepared by the Institute of Laboratory Animal Resources, and published by the National Institutes of Health. All animal protocols were approved by the responsible local authority (''Amt für Gesundheit und Verbraucherschutz, Hansestadt (Office for Health and Consumer Protection) Hamburg'').
1. Catheter Preparation
NOTE: Refer to the Table of Materials for information regarding the catheter.
2. Mouse preparation
3. Histopathology
4. Immunofluorescence Microscopy
Balloon denudation is a suitable model to study the development of MH in mice. Animals recover well from the surgery and show an excellent physical condition post-operation. We established this model in 50 mice with less than 3% death rate due to the surgical procedure. Figures 1B-C show the key surgical steps. After a skin incision along the linea alba, identify the aorta abdominalis. Place microsurgical clamps (Figure 1B). Make a small incision in the middle of aorta, set a balloon catheter into the vessel and slide it retrograde, against the direction of blood flow (Figure 1C). Movement of the inflated balloon leads to scraping of intima and, at the same time, overdistension of the vessel. The aortic incision will be closed with single stiches. An aortic pulse should be visible distally from the incision.
MH develops progressively in the graft over time. Histological staining with Masson's trichrome demonstrates myointima formation inside the internal elastic lamina (Figure 2A). Myointimal lesions consisted mainly of cellular components positive for SM22 and some extracellular matrix components (Figure 2B). Myointimal cells are further evaluated by immunofluorescence staining. The main population in the myointima consists of smooth muscle (smooth muscle actin (SMA) positive) cells and myofibroblasts (fibroblast activation protein (FAP) positive) cells (Figure 2B).
Figure 1. Schematics of the catheter and its implantation. (A) Detailed schematic of the catheter. Distal port, balloon, rapid exchange port (RX-port), guidewire, single lumen to RX-port, double lumens from RX-Port to balloon, hub, balloon inflation port. (B) Schematic illustration of surgical procedure. Blood flow of the Aorta abdominalis is stopped with two micro clamps and a small incision is performed. C. Inflated catheter inside aorta abdominalis. Please click here to view a larger version of this figure.
Figure 2. Myointima formation inside the internal elastic lamina. (A) Denuded mouse aortas are harvested, paraffin embedded, and a representative cross section is shown in trichrome staining. (B) Double immunofluorescence staining of balloon-denuded aortae is shown. The upper row depicts myointimal lesions stained for SM22 and collagen III. In the bottom row, vessels are stained for SMA and FAP. Please click here to view a larger version of this figure.
This article demonstrates a murine model to study the development of myointimal hyperplasia and allows the exploration of the underlying pathological processes and the testing of new drugs or therapeutic options.
The most critical step in this protocol is the denudation of the aorta. Special care should be paid during this step as excessive denudation will lead to aneurysm formation and model failure. On the other hand, if denudation is performed insufficiently, too little myointima will develop. Therefore, the intensity of the denudation step is crucial for the outcome and success of this animal model.
With respect to the surgical procedure, it is critical the two walls of the vessel are not pierced by setting the stiches, which might result in early failure of the vessel patency. We have previously described a mouse model in which we induced vessel stenosis in the abdominal aorta of mice18. However, this and most other models only provide very small amounts of tissue for analysis. An advantage of this method is the comparatively large amount of tissue obtained (~1 cm vessel segment). A single vessel graft can thus be divided into multiple parts and used for various analyses, effectively reducing the number of experimental animals required.
Furthermore, suitable knock-out animals can be used to study the development of myointima hyperplasia in different disease conditions. The genetic backgrounds can also be combined with this animal model to understand the mechanisms of myointimal hyperplasia in a variety of settings or the impact of certain genes.
In summary, the model described here is reproducible, easy to perform, and can be established quickly and reliably. Successfully tested treatment options in this model can be further confirmed in large animal models19.
The authors have nothing to disclose.
The authors thank Christiane Pahrmann for her technical assistance.
D.W. was supported by the Max Kade Foundation. T.D. received grants from the Else Kröner Fondation (2012_EKES.04) and the Deutsche Forschungsgemeinschaft (DE2133/2-1_. S. S. received research grants from the Deutsche Forschungsgemeinschaft (DFG; SCHR992/3- 1, SCHR992/4-1).
10-0 Ethilon suture | Ethicon | 2814G | |
3 mL Syringe | BD Medical | 309658 | |
37% HCl | Sigma-Aldrich | H1758 | |
5-0 prolene suture | Ethicon | EH7229H | |
6-0 prolene suture | Ethicon | 8706H | |
Acid Fuchsin | Sigma-Aldrich | F8129-25G | Trichrome staining |
Antigen retrieval solution | Dako | S1699 | |
Azophloxin | Waldeck | 1B-103 | Trichrome staining |
Bepanthen Eye and Nose ointment | Bayer | 1578675 | Eye ointment |
Betadine Solution | Betadine Purdue Pharma | NDC:67618-152 | |
C57BL/6J | Charles River | Stock number 000664 | |
Clamp applicator | Fine Science Tools | 18056-14 | |
Collagen 3 | abcam | ab7778 | Antibody |
DAPI | Thermo Fischer | D1306 | |
Donkey anti-Goat IgG AF555 | Invitrogen | A21432 | Secondary antibody |
Donkey anti-Rabbit IgG AF488 | Invitrogen | A21206 | Secondary antibody |
Donkey anti-Rabbit IgG AF488 | Invitrogen | A11055 | Secondary antibody |
Donkey anti-Rabbit IgG AF555 | Invitrogen | A31572 | Secondary antibody |
Ethanol 70% | Th. Geyer | 2270 | |
Ethanol 96% | Th. Geyer | 2295 | |
Ethanol absolute | Th. Geyer | 2246 | |
FAP | abcam | ab28246 | Antibody |
Forceps fine | Fine Science Tools | 11251-20 | |
Forceps standard | Fine Science Tools | 11023-10 | |
Glacial Acetic Acid | Sigma-Aldrich | 537020 | |
Hair clipper | WAHL | 8786-451A ARCO SE | |
Heparin | Rotexmedica | PZN 3862340 | 25.000 I.E./mL |
High temperature cautery kit | Bovie | 18010-00 | |
Image-iT FX Signal Enhancer | Invitrogen | I36933 | Blocking solution |
Light Green SF | Waldeck | 1B-211 | Trichrome staining |
Microsurgical clamp | Fine Science Tools | 18055-04 | Micro-Serrefine – 4mm |
MINI TREK Coronary Dilatation Catheter 1.20 mm x 6 mm / Rapid-Exchange | Abbott | 1012268-06U | |
Molybdatophosphoric acid hydrate | Merck | 1.00532.0100 | Trichrome staining |
NaCl 0,9% | B.Braun | PZN 06063042 Art. Nr.: 3570160 | |
Needle holder | Fine Science Tools | 12075-14 | |
Novaminsulfon | Ratiopharm | PZN 03530402 | Metamizole |
Orange G | Waldeck | 1B-221 | Trichrome staining |
Paraffin | Leica biosystems | REF 39602004 | |
PBS pH 7,4 | Gibco | 10010023 | |
PFA 4% | Electron Microscopy Sciences | #157135S | |
Ponceau S solution | Serva Electrophoresis | 33427 | Trichrome staining |
Primary antibody diluent | Dako | S3022 | |
Prolong Gold Mounting solution | Thermo Fischer | P36930 | Mounting solution for immunofluorescence stained slides |
Replaceable Fine Tip | Bovie | H101 | |
Resorcin-Fuchsin Weigert | Waldeck | 2E-30 | Trichrome staining |
Rimadyl | Pfizer | 400684.00.00 | Carprofen |
Scissors | Fine Science Tools | 14028-10 | |
Scissors Vannas-style | Fine Science Tools | 15000-03 | |
Secondary antibody diluent | Dako | S0809 | |
Fast acting Adhesive MINIS 3x1g | UHU | 45370 | Cyanoacrylate |
Slide Rack | Ted Pella | 21057 | |
SM22 | abcam | ab10135 | Antibody |
SMA | abcam | ab21027 | Antibody |
Staining dish | Ted Pella | 21075 | |
Surgical microscope | Leica | M651 | |
Tabotamp fibrillar | Ethicon | 431962 | Absorbable hemostat |
Transpore Surgical Tape | 3M | 1527-1 | |
U-100 Insulin syringe | BD Medical | 324825 | |
Vessel Dilator | Fine Science Tools | 18603-14 | |
Vitro-Clud | Langenbrinck | 04-0001 | |
Weigerts iron hematoxylin Kit | Merck | 1.15973.0002 | Trichrome staining |
Xylene | Th. Geyer | 3410 |